3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
406
Sarcoma
34
Gastrointestinal
29
Lymphoid
24
Genitourinary
20
Myeloid
15
Head & Neck
12
Dermatologic
12
Thoracic
11
Other hematologic neoplasm
10
Endocrine
8
Breast
5
Plasma cell
4
Gynecologic
4
NET
2
Other solid neoplasm
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
58
Anemia, Refractory, with Excess of Blasts
49
Myelodysplastic Syndromes
44
Venous Thromboembolism
33
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Anemia, Aplastic
26
Myeloproliferative Disorders
25
Lymphoma, Non-Hodgkin
23
Neoplasms
22
Multiple Myeloma
20
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
20
Anemia
20
Leukemia, Myelomonocytic, Chronic
19
Hodgkin Disease
19
Thrombocytopenia
18
Primary Myelofibrosis
18
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia
18
Hematologic Neoplasms
17
Lymphoma
15
Anemia, Sickle Cell
13
Lymphoma, Follicular
11
Fanconi Anemia
11
Cytopenia
11
Venous Thrombosis
10
Bone Marrow Failure Disorders
10
Pulmonary Embolism
9
Leukemia, Biphenotypic, Acute
9
Febrile Neutropenia
9
Polycythemia Vera
8
Interventions
apixaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Classical hematology
×
1 year
×
Clear all
NCT05683808
2026-01-30
VTE-POG
University of Vermont Medical Center
Phase 2
Recruiting
40 enrolled